CLARUS THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities
CLARUS THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Accrued Liabilities of $1.57 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was -$1.60M, a 145.30% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was $3.17M, a 11.76% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was $889.00K, a 25.11% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for the quarter ending 2021-09-30 was -$3.63M.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2021 was $3.63M, a 26.71% increase from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. increase (decrease) in accrued liabilities for fiscal 2020 was $2.86M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $1.57M 10-Q · filed 2022-08-19 | $2.46M derived: sum of 3 quarters · filed 2022-08-19 | -$1.17M derived: sum of 4 quarters · filed 2022-08-19 | ||
| 2022-03-31 | $3.17M 10-Q · filed 2022-05-16 | $4.06M derived: sum of 2 quarters · filed 2022-05-16 | $433.00K derived: sum of 3 quarters · filed 2022-05-16 | $3.96M derived: sum of 4 quarters · filed 2022-08-19 | ||
| 2021-12-31 | $889.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$2.74M derived: sum of 2 quarters · filed 2022-03-31 | $790.00K derived: sum of 3 quarters · filed 2022-08-19 | $3.63M 10-K · filed 2022-03-31 | ||
| 2021-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$99.00K derived: sum of 2 quarters · filed 2022-08-19 | $2.74M 10-Q · filed 2021-11-19 | $3.93M derived: sum of 4 quarters · filed 2022-08-19 | ||
| 2021-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-19 | $6.37M 10-Q · filed 2022-08-19 | $742.30K 10-Q · filed 2021-08-16 | $7.56M derived: sum of 3 quarters · filed 2022-08-19 | ||
| 2021-03-31 | $2.84M 10-Q · filed 2022-05-16 | $253.19K 10-Q · filed 2021-05-26 | $4.03M derived: sum of 2 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.86M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $1.68M 10-Q · filed 2021-11-19 |